All News

Found 785,239 articles

• Geron Corporation Announces Presentation Of New Data Supporting The Utility Of Its Small Molecule Telomerase Activator Drugs For HIV/AIDS Therapy

  2/3/2006

• Researchers See Hope For Sex Disease Vaccine

  2/3/2006

• Nucleotide Supplements May Protect Digestive Tract

  2/3/2006

• Broccoli Compound Has "Lasting Effect On Offspring"

  2/3/2006

• Amgen Continues Manufacturing Expansion With Additional $1 Billion Investment In Puerto Rico

  2/3/2006

• IPO Watch: IOMAI Corporation

  2/3/2006

• The Day In Review: InterMune, Inc. Stops Trial, Stock Slumps

  2/3/2006

• Biologics License Application For Gardasil(R), Merck & Co., Inc.'s Investigational Cervical Cancer Vaccine, Is On Track

  2/3/2006

• HealthSpring, Inc. Announces Pricing Of Initial Public Offering Of Common Stock

  2/3/2006

• DOV Pharmaceutical Announces Completion Of Enrollment In Its Phase III Clinical Trial Of Bicifadine In Chronic Low Back Pain

  2/3/2006

• Shire Pharmaceuticals Group plc Announces European Filings Of SPD476 (Mesalazine) For Treatment Of Ulcerative Colitis

  2/3/2006

• Alexion Pharmaceuticals Inc. Provides Update On APEX-AMI Trial

  2/3/2006

• Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Release: Recruitment Of Patients For The Phase II Study In Stress Urinary Incontinence With Cizolirtine Drug Has Been Completed

  2/3/2006

• Micromet Release: New Study Supports Ep-CAM As Prime Target For Antibody Therapy In Common Cancers

  2/3/2006

• OXiGENE To Commence A Randomized Clinical Trial In The United States To Evaluate CA4P For The Treatment Of Patients With Non Small Cell Lung Cancer (NSCLC)

  2/3/2006

• Evotec OAI (United Kingdom) Successfully Completes Single Ascending Dose Component Of Phase I Trial With EVT 101 For Alzheimer's Disease

  2/3/2006

• Ecopia BioSciences Inc. Receives No Objection Letter From Health Canada For Cancer Phase I Clinical Trial

  2/3/2006

• Regeneration Technologies Inc.'s VEGF Trap Demonstrates Positive Preliminary Results In Patients With Age-Related Macular Degeneration

  2/3/2006

• The American Journal Of Psychiatry Publishes Data On Clinical Trial Of Nalmefene In The Treatment Of Pathological Gambling

  2/3/2006

• Chromos Molecular Systems Inc. Completes Acquisition Of Targeted Molecules Corporation And Closes Cdn. $6 Million Financing

  2/3/2006